Annual FCF
-$106.72 M
+$5.41 M+4.82%
December 31, 2023
Summary
- As of February 12, 2025, ITOS annual free cash flow is -$106.72 million, with the most recent change of +$5.41 million (+4.82%) on December 31, 2023.
- During the last 3 years, ITOS annual FCF has fallen by -$81.19 million (-317.99%).
- ITOS annual FCF is now -120.85% below its all-time high of $511.96 million, reached on December 31, 2021.
Performance
ITOS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$37.45 M
-$3.08 M-8.95%
September 30, 2024
Summary
- As of February 12, 2025, ITOS quarterly free cash flow is -$37.45 million, with the most recent change of -$3.08 million (-8.95%) on September 30, 2024.
- Over the past year, ITOS quarterly FCF has dropped by -$22.28 million (-146.98%).
- ITOS quarterly FCF is now -106.19% below its all-time high of $604.47 million, reached on September 30, 2021.
Performance
ITOS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$120.32 M
-$2.80 M-2.39%
September 30, 2024
Summary
- As of February 12, 2025, ITOS TTM free cash flow is -$120.32 million, with the most recent change of -$2.80 million (-2.39%) on September 30, 2024.
- Over the past year, ITOS TTM FCF has dropped by -$13.60 million (-12.74%).
- ITOS TTM FCF is now -121.28% below its all-time high of $565.34 million, reached on September 30, 2021.
Performance
ITOS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ITOS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | -147.0% | -12.7% |
| 3 y3 years | -318.0% | -106.2% | -121.3% |
| 5 y5 years | -452.3% | -567.7% | -404.1% |
ITOS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -120.8% | +4.8% | -147.0% | +36.5% | -123.5% | +16.3% |
| 5 y | 5-year | -120.8% | +4.8% | -106.2% | +36.5% | -121.3% | +16.3% |
| alltime | all time | -120.8% | +4.8% | -106.2% | +36.5% | -121.3% | +16.3% |
ITeos Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.45 M(+8.9%) | -$120.32 M(+2.4%) |
| Jun 2024 | - | -$34.37 M(+3.1%) | -$117.52 M(+3.6%) |
| Mar 2024 | - | -$33.34 M(+119.9%) | -$113.39 M(+6.3%) |
| Dec 2023 | -$106.72 M(-4.8%) | -$15.16 M(-56.2%) | -$106.72 M(-10.2%) |
| Sep 2023 | - | -$34.64 M(+14.5%) | -$118.85 M(+4.3%) |
| Jun 2023 | - | -$30.25 M(+13.4%) | -$113.99 M(-0.5%) |
| Mar 2023 | - | -$26.67 M(-2.3%) | -$114.58 M(+2.2%) |
| Dec 2022 | -$112.13 M(-121.9%) | -$27.29 M(-8.4%) | -$112.13 M(-22.0%) |
| Sep 2022 | - | -$29.78 M(-3.4%) | -$143.82 M(-129.3%) |
| Jun 2022 | - | -$30.83 M(+27.3%) | $490.43 M(-2.4%) |
| Mar 2022 | - | -$24.23 M(-58.9%) | $502.61 M(-1.8%) |
| Dec 2021 | $511.96 M | -$58.98 M(-109.8%) | $511.96 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $604.47 M(-3340.1%) | $565.34 M(-1242.9%) |
| Jun 2021 | - | -$18.66 M(+25.4%) | -$49.47 M(+20.9%) |
| Mar 2021 | - | -$14.88 M(+165.8%) | -$40.90 M(+60.2%) |
| Dec 2020 | -$25.53 M(+7.0%) | -$5.60 M(-45.8%) | -$25.53 M(-4.9%) |
| Sep 2020 | - | -$10.33 M(+2.4%) | -$26.86 M(+21.4%) |
| Jun 2020 | - | -$10.09 M(-2143.3%) | -$22.14 M(+22.8%) |
| Mar 2020 | - | $494.00 K(-107.1%) | -$18.03 M(-24.5%) |
| Dec 2019 | -$23.87 M(+23.5%) | -$6.93 M(+23.5%) | -$23.87 M(+40.9%) |
| Sep 2019 | - | -$5.61 M(-6.3%) | -$16.94 M(+49.5%) |
| Jun 2019 | - | -$5.99 M(+12.0%) | -$11.33 M(+112.0%) |
| Mar 2019 | - | -$5.35 M | -$5.35 M |
| Dec 2018 | -$19.32 M | - | - |
FAQ
- What is iTeos Therapeutics annual free cash flow?
- What is the all time high annual FCF for iTeos Therapeutics?
- What is iTeos Therapeutics annual FCF year-on-year change?
- What is iTeos Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly FCF year-on-year change?
- What is iTeos Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for iTeos Therapeutics?
- What is iTeos Therapeutics TTM FCF year-on-year change?
What is iTeos Therapeutics annual free cash flow?
The current annual FCF of ITOS is -$106.72 M
What is the all time high annual FCF for iTeos Therapeutics?
iTeos Therapeutics all-time high annual free cash flow is $511.96 M
What is iTeos Therapeutics annual FCF year-on-year change?
Over the past year, ITOS annual free cash flow has changed by +$5.41 M (+4.82%)
What is iTeos Therapeutics quarterly free cash flow?
The current quarterly FCF of ITOS is -$37.45 M
What is the all time high quarterly FCF for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly free cash flow is $604.47 M
What is iTeos Therapeutics quarterly FCF year-on-year change?
Over the past year, ITOS quarterly free cash flow has changed by -$22.28 M (-146.98%)
What is iTeos Therapeutics TTM free cash flow?
The current TTM FCF of ITOS is -$120.32 M
What is the all time high TTM FCF for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM free cash flow is $565.34 M
What is iTeos Therapeutics TTM FCF year-on-year change?
Over the past year, ITOS TTM free cash flow has changed by -$13.60 M (-12.74%)